Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16416235 | 0.98 | NOS1 (0.43) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL647661 | 0.79 | MLYCD (0.53) | MLYCD | |
| SCHEMBL179484 | 0.76 | NOS1 (0.50) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL27548506 | 0.76 | NOS1 (0.44) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL22736793 | 0.74 | NOS1 (0.43) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL9572166 | 0.73 | TRPM5 (0.33) | TRPM5 | |
| SCHEMBL31078390 | 0.73 | ALDH1A1 (0.34) | ALDH1A1TRPM5MLYCD | |
| SCHEMBL3188826 | 0.73 | NOS1 (0.46) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL5875565 | 0.73 | NOS1 (0.42) | NOS1ALDH1A1HPGDALOX15MYC | |
| SCHEMBL22511316 | 0.71 | TRPM5 (0.32) | TRPM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108264507-A | 6- phenethyl -4- hydroxyls -2（1H）The preparation method and applications of pyridone -3- carboxamides derivatives | 北京大学 | 2018-07-10 | — | — | CN | claimed |
| CN-101768135-B | Preparation method of 2-amino-5-trifluoromethyl thiazole | SHANGHAI INST ORGANIC CHEM | 2012-07-11 | — | — | CN | claimed |
| CN-101768135-A | Preparation method of 2-amino-5-trifluoromethyl thiazole | SHANGHAI INST ORGANIC CHEM | 2010-07-07 | — | — | CN | claimed |
| US-20250353853-A1 | FLAVIVIRUS INHIBITORS | IRBM S.P.A. (IT) | 2025-11-20 | — | — | US | disclosed |
| WO-2025235298-A1 | BIFUNCTIONAL COMPOUNDS CONTAINING THIAZOLYL DERIVATIVES FOR DEGRADING CERTAIN CYCLIN-DEPENDENT KINASE VIA UBIQUITIN PROTEASOME PATHWAY | NIKANG THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| EP-4643954-A2 | NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Daewoong Pharmaceutical Co., Ltd. (KR) | 2025-11-05 | — | — | EP | disclosed |
| EP-4616913-A2 | GCN2 INHIBITORS AND USES THEREOF | Merck Patent GmbH (DE) | 2025-09-17 | — | — | EP | disclosed |
| EP-3746075-B1 | GCN2 INHIBITORS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-4583870-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | Mito Biopharma, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025104236-A1 | PYRAZOLE COMPOUNDS AS CULLIN RING UBIQUITIN LIGASE COMPOUNDS | PROXYGEN GMBH (AT) | 2025-05-22 | — | — | WO | disclosed |
| EP-4532476-A1 | FLAVIVIRUS INHIBITORS | IRBM S.P.A. (IT) | 2025-04-09 | — | — | EP | disclosed |
| WO-1995033719-A1 | SUBSTITUTED PYRROLIDONE, THIAZOLIDONES OR OXAZOLIDONES AS HERBICIDES | ZENECA LIMITED (GB) | 1995-12-14 | — | — | WO | disclosed |
| EP-0282978-B1 | Surface acoustic wave convolver with dielectric film of high non-linear effect | CANON KK (JP) | 1993-12-01 | — | — | EP | disclosed |
| EP-0284229-B1 | NONLINEAR OPTICAL MATERIAL AND METHOD FOR ORIENTATION THEREOF | CANON KABUSHIKI KAISHA (JP) | 1993-07-21 | — | — | EP | disclosed |
| US-5037582-A | Nonlinear optical material and method for orientation thereof | CANON KABUSHIKI KAISHA (JP) | 1991-08-06 | — | — | US | disclosed |
| US-4946261-A | Recording method and recording apparatus | CANON KABUSHIKI KAISHA (JP) | 1990-08-07 | — | — | US | disclosed |
| US-4882715-A | Surface acoustic wave convolver with dielectric film of high non-linear effect | CANON KABUSHIKI KAISHA (JP) | 1989-11-21 | — | — | US | disclosed |
| EP-0295145-A2 | Recording method and recording apparatus | CANON KABUSHIKI KAISHA (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0284229-A1 | Nonlinear optical material and method for orientation thereof | CANON KABUSHIKI KAISHA (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0282978-A2 | Surface acoustic wave convolver with dielectric film of high non-linear effect | CANON KABUSHIKI KAISHA (JP) | 1988-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353853-A1 | FLAVIVIRUS INHIBITORS | SPINT2, EIF2AK2, DDX5 | NOS1 2569/4885ALDH1A1 3259/4885HPGD 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.